NASDAQ: ETONEton Pharmaceuticals Inc Stock Ownership - Who owns Eton Pharmaceuticals?
Insider buying vs selling
Have Eton Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul V. Maier | Director | 2026-08-28 | 36,387 | $58.64 | $2.13MSell |
| Paul V. Maier | Director | 2026-08-28 | 12,500 | $7.31 | $91.38kBuy |
| Paul V. Maier | Director | 2026-08-28 | 128 | $61.77 | $7.91kSell |
| Paul V. Maier | Director | 2026-08-28 | 13,485 | $60.21 | $811.93kSell |
| Paul V. Maier | Director | 2026-08-28 | 36,387 | $58.64 | $2.13MSell |
| Paul V. Maier | Director | 2026-08-28 | 50,000 | $3.78 | $189.00kBuy |
| Paul V. Maier | Director | 2026-08-28 | 128 | $61.77 | $7.91kSell |
| Paul V. Maier | Director | 2026-08-28 | 13,485 | $60.21 | $811.93kSell |
| Paul V. Maier | Director | 2026-08-28 | 36,387 | $58.64 | $2.13MSell |
| Paul V. Maier | Director | 2026-08-28 | 50,000 | $3.78 | $189.00kBuy |
ETON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ETON insiders and whales buy or sell their stock.
ETON Shareholders
What type of owners hold Eton Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Opaleye Management Inc | 18.93% | 5,410,000 | $281.21M | Insider |
| Harrow Health Inc | 6.93% | 1,982,000 | $103.02M | Insider |
| Sean Brynjelsen | 3.45% | 986,134 | $51.26M | Insider |
| Norbert G. Riedel | 0.78% | 224,300 | $11.66M | Insider |
| James R. Gruber | 0.75% | 213,420 | $11.09M | Insider |
| Paul V. Maier | 0.25% | 72,245 | $3.76M | Insider |
| Charles J. Casamento | 0.24% | 68,420 | $3.56M | Insider |
| David Krempa | 0.13% | 37,025 | $1.92M | Insider |
| William Wilson Troutman | 0.08% | 23,027 | $1.20M | Insider |
| Danka Radosavljevic | 0.08% | 22,473 | $1.17M | Insider |
ETON vs Pharmaceutical Stocks
Eton Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.